MAXHEALTH - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

IntraDay Trade Rating: 3.3

💹 Optimal Buy Price: ₹1,130–₹1,135 (near short-term support and below current price)

🎯 Profit Target: ₹1,150–₹1,160 (minor resistance zone)

🛡️ Stop Loss: ₹1,120 (below recent support and psychological level)

📊 Exit Strategy if Already Holding: Consider exiting near ₹1,155 if RSI approaches 45 and MACD flattens. Watch for volume spikes and price rejection near ₹1,160.

✅ Positive

• 📈 PAT of ₹166 Cr shows consistent profitability
• 📊 DII holding increased by 2.62%, indicating strong domestic investor confidence
• 📉 Debt-to-equity ratio of 0.07 reflects financial prudence
• 📊 Volume today (22.7L) is slightly above 1-week average (22.1L)
• 📈 Trading near 200 DMA, offering long-term support

⚠️ Limitation

• 📉 RSI at 41.7 and MACD at -0.58 indicate weak momentum
• 📉 Stock trading below 50 DMA (₹1,173), showing near-term pressure
• 📉 High P/E of 145 vs industry average of 57.2 suggests overvaluation
• 📉 PEG ratio of 4.58 indicates expensive valuation relative to growth
• 📉 FII holding declined by 2.96%

🚫 Company Negative News

• 📉 No major negative news reported recently

📢 Company Positive News

• 📈 Stable PAT and EPS of ₹7.33 despite sector volatility
• 📊 Strong DII inflows suggest institutional support from domestic investors

🏭 Industry

• 🏥 MAXHEALTH operates in the healthcare services sector, which remains defensive and stable
• 📈 Industry P/E of 57.2 supports long-term valuation potential

🧾 Conclusion

📌 MAXHEALTH presents a moderately cautious intraday setup today with stable fundamentals and rising volume, but weak technical momentum and high valuation. Traders may consider entering near ₹1,132 with a target of ₹1,155 and stop loss at ₹1,120. If already holding, monitor RSI and MACD for exit signals near resistance.

I can also help you compare MAXHEALTH’s setup with other hospital or diagnostics stocks showing stronger intraday momentum.